Extracorporeal Shockwave Therapy
8
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
Polydeoxyribonucleotide for Elbow Lateral Epicondylitis
Effect of Extracorporeal Shockwave Therapy on Gait Parameters in Patients With Planter Fascitis
Effect of Ultrasound-guided Piriformis Muscle Corticosteroid Injection Versus Extracorporeal Shock Wave Therapy for Piriformis Syndrome: a Randomized Control Trial
Comparison of Focused Shock Waves or Ultrasound-Guided Needling and Lavage in Patients With Calcifying Tendinopathy of the Shoulder
Early Radial Shock Waves Treatment on Spasticity in Patients With Stroke in Sub-acute Phase
Effects of Radial Shock Waves Therapy in the Treatment of Neck Pain
Early Extracorporeal Shockwave Therapy for Erectile Dysfunction in Radically Prostatectomised Men.